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Abstract
Background: In humans trophoblast invasion and vascular remodeling are critical to determine
the fate of pregnancy. Since guinea-pigs share with women an extensive migration of the
trophoblasts through the decidua and uterine arteries, and a haemomonochorial placenta, this
species was used to evaluate the spatio-temporal expression of three enzymes that have been
associated to trophoblast invasion, MMP-2, MMP-9 and tissue kallikrein (K1).
Methods: Uteroplacental units were collected from early to term pregnancy. MMP-2, MMP-9 and
K1 were analysed by immunohistochemistry and Western blot. The activities of MMP-2 and MMP-
9 were assessed by gelatin zymography.
Results: Immunoreactive MMP-2, MMP-9 and K1 were detected in the subplacenta, interlobar and
labyrinthine placenta, syncytial sprouts and syncytial streamers throughout pregnancy. In late
pregnancy, perivascular or intramural trophoblasts expressed the three enzymes. The intensity of
the signal in syncytial streamers was increased in mid and late pregnancy for MMP-2, decreased in
late pregnancy for MMP-9, and remained stable for K1. Western blots of placental homogenates at
days 20, 40 and 60 of pregnancy identified bands with the molecular weights of MMP-2, MMP-9 and
K1. MMP-2 expression remained constant throughout gestation. In contrast, MMP-9 and K1
attained their highest expression during midgestation. Placental homogenates of 20, 40 and 60 days
yielded bands of gelatinase activity that were compatible with MMP-2 and MMP-9 activities.
ProMMP-2 and MMP-9 activities did not vary along pregnancy, while MMP-2 and MMP-9 increased
at 40 and 40–60 days  respectively.
Conclusion: The spatio-temporal expression of MMPs and K1 supports a relevant role of these
proteins in trophoblast invasion, vascular remodeling and placental angiogenesis, and suggests a
functional association between K1 and MMP-9 activation.
Background
The establishment of pregnancy requires that trophoblasts
attach to the uterine epithelium, invade the
endometrium, colonize the spiral arteries and acquire an
endothelial phenotype, to establish a continuum between
the intervillous space and the maternal circulation [1,2].
The disturbance of these tightly spatio-temporally regu-
lated processes causes important obstetrical and neonatal
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complications, ranging from miscarriages due to impaired
attachment, to the extensive invasion of placenta accreta.
A shallow invasion, on the other hand, results in a hypop-
erfused placenta which sheds to the maternal circulation
microvillus particles, reactive oxygen species, asymmetric-
di-methyl-arginine, cytokines, provoking the preeclamp-
sia syndrome [3,4]. Therefore, the invasive process is crit-
ical to determine the fate of pregnancy.
Several studies have provided evidence that invasive tro-
phoblasts secrete matrix metalloproteinases (MMPs), a
family of Zn2+-dependent endopeptidases that degrade
extracellular matrix (ECM) and basement membrane
components [5,6]. Two of the most studied members of
this family are MMP-2 (gelatinase A, 72 kDa) and MMP-9
(gelatinase B, 92 kDa), which degrade a wide range of sub-
strates, including type IV collagen, the main type of colla-
gen found in basement membranes. MMPs are secreted as
proenzymes into the ECM, where they are activated by
proteolytic cleavage of their amino terminal domain by
membrane-associated MMPs and extracellular proteases.
The activity of MMPs is also regulated by binding to differ-
ent tissue inhibitors of MMPs (TIMPs). MMP-2, MMP-9
and TIMPs are expressed in human, sheep, rat and mice
reproductive tissues, and have been implicated in the
invasion and development of the placental fetal villous
tree; in addition, these proteins participate in the detach-
ment of the placenta and membranes in labor [7-15].
Tissue kallikrein (K1) is a serine protease that cleaves low-
molecular weight kininogen to generate kinins (kallidin
and bradykinin). Kinins induce vasodilation and increase
vascular permeability, either directly or by stimulating the
synthesis of nitric oxide (NO) and angiotensin-(1–7)
through the type-2 bradykinin receptor (B2R). Moreover,
kinins have been shown to enhance mitogenesis and ang-
iogenesis [16]. In humans, K1 and B2R are found in syn-
cytiotrophoblasts, and in invasive and intravascular
trophoblasts, along with endothelial NO synthase, angi-
otensin-(1–7) and angiotensin-converting enzyme type-2
[17,18]. K1 has the capacity to activate MMP-9 in vitro
[19-21], and could participate in the degradation of extra-
cellular matrix.
The aim of the present study was to assess the spatio-tem-
poral expression of MMP-2, MMP-9 and K1 in utero-pla-
cental units of the pregnant guinea-pig, using
immunohistochemistry and Western blot analysis; in
addition, the activities of MMP-2 and MMP-9 were evalu-
ated with gelatin zymography. The guinea-pig pregnancy
shares several structural similarities with the human gesta-
tion, regarding the trophoblastic interstitial and vascular
invasion and the haemomonochorial placenta [22-24].
Moreover, the guinea-pig has been postulated as an ideal
model to study the role of the tissue kallikrein-kinin sys-
tem [25,26].
Methods
Guinea-pigs (Pirbright white ~600 g) were kept under
controlled conditions of humidity, temperature and light
cycle. Females were examined daily, and when vaginal
opening was observed they were caged with fertile males.
The day in which sperm was observed in vaginal smears
was defined as day one of pregnancy; from then onwards
ascorbic acid was added to the drinking water. Litter size
varied from 2–5 fetuses.
The experiments were conducted according to the Guide
for the Care and Use of Laboratory Animals (National
Research Council, USA). The animals were deeply anes-
thetized with a mixture of ketamine (100 mg/kg) and
xylazine (4 mg/kg) given intraperitoneally. Thirty dams
were sacrificed in early, mid- and late pregnancy. The
uterus and feto-placental units were removed and a cen-
tral slice through the placenta, subplacenta, implantation
site and underlying myometrium was fixed as a single
block of tissue. In addition, the placenta, endometrium,
and mesometrium were separately dissected. The animals
were euthanized with an overdose of anesthetic. Tissues
were fixed immediately with phosphate-buffered 4% for-
malin for 24 h or snap frozen in liquid nitrogen and kept
at -70°C. The fixed tissues were dehydrated in a graded
series of ethanol, xylene and embedded in Paraplast-Plus®
(Sigma, St. Louis, MO). Sections (5 μm) were mounted on
silanized slides.
Immunostaining procedure
All immunostaining procedures were performed at room
temperature; deparaffinized sections were rehydrated
through ethanol, rinsed three times for five minutes in
PBS-50 mM Tris-HCl and submitted to heat antigen
retrieval using citrate buffer pH 6.0 for K1 and Tris-HCl-
EDTA pH 9.0 for MMPs. Endogenous peroxidases were
blocked with incubation in 10% H2O2 for ten minutes.
Sections were incubated in a humid chamber for 30 min-
utes with protein block (Cas-Block®, Zymed, San Fran-
cisco, CA) followed by incubation for 18 h at 4°C with the
primary antibodies: mouse monoclonal anti-MMP-2
(clone 75-7F7, 2 μg/ml), anti-MMP-9 (clone 56-2A4, 2
μg/ml) from Oncogene Research, San Diego, CA and rab-
bit polyclonal antiserum against purified rat urinary K1
(1:2000) [27]. These antibodies recognize both active and
latent forms. Sections were immunostained using a
biotin-streptavidin-peroxidase system (LSAB+®, DakoCy-
tomation, Carpinteria, CA). Finally, the samples were
treated for 15 minutes with 0.1% (w/v) 3-3'-diaminoben-
zidine in buffer containing 0.05% H2O2. The slides were
counterstained with Harris hematoxylin (Sigma, St. Louis,
MO).Reproductive Biology and Endocrinology 2007, 5:27 http://www.rbej.com/content/5/1/27
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Cytotrophoblasts were identified by staining with an anti-
pancytokeratin mouse monoclonal antibody (1:100,
P2871, Sigma, St. Louis, MO). Smooth muscle and
endothelial cells were characterized with antibodies
against  α-smooth muscle actin (1A4, 1:1500), muscle
actin (clone HHF35, 1:1000) and von Willebrand factor
(A0082, 1:400) obtained from DakoCytomation (Carpin-
teria, CA). The specificity of the staining was determined
by incubation of sections in the absence of the first anti-
body.
Immunohistochemical image analysis
The immunostained sections of the subplacenta and
decidua were photographed with a Nikon CoolPix 4500
(Nikon Inc., Tokyo, Japan) camera coupled to a Zeiss
AxioImager AX.10 microscope (Carl Zeiss, CA) using a
20× objective with a 0.32 μm/pixel resolution. The lumi-
nance of the incident light was calibrated for each section
in order to assign pixel values from 0 to 255 (no light to
full light transmission). A total of one hundred and forty
five subplacental and decidual fields were photographed
from sections obtained from dams in each of the follow-
ing periods: early (20 days), mid (40 days) and late (60
days) pregnancy. A total of 12–16 fields were analyzed for
MMP-2, MMP-9 and K1 immunohistochemistry at each
gestation period. The images were loaded into the ImageJ
v.1.34 software (National Institutes of Health, Bethesda,
MD) for analysis. A total of 243 syncytial streamers were
manually delineated, extracted from the surrounding tis-
sue to a separate image file and saved in tiff format. MMP-
2, MMP-9 and K1 immunoreactive signals were extracted
from the images with a color deconvolution algorithm
[28], integrated in the ImageJ software. After conversion
of pixel luminosity values to an optical density scale, the
integrated optical density was measured in the previously
extracted positive staining images and normalized by the
positive area in each microphotograph. The signal inten-
sity (I) was calculated as I = 10·∑OD/A in dB/μm2, being
∑OD the integrated optical density, and A the area of pos-
itive staining (μm2).
Protein extraction
Total proteins from placenta from early, mid and late
pregnancy were extracted using 5 ml/g of 20 mM Tris-HCl
buffer containing 10 mM EDTA, 2 mM phenylmethylsul-
fonylfluoride, 5 μM leupeptin, 50 μg/ml soybean trypsin
inhibitor, 0.05% Brij-35 and 0.02% NaN3 at pH 7.4. Tis-
sues were homogenized with a Tekmar Tissumizer
(Cincinnati, OH) for one minute on ice. Crude homoge-
nates were centrifuged at 4000 rpm for 20 minutes, then
0.2% SDS was added to the supernatant, kept for 1 hour
at 4°C, centrifuged at 14000 rpm for 20 min at 4°C and
finally stored at -70°C. Protein content was determined
according to the Lowry method [29].
In subsequent sections of a uteroplacental unit obtained in day 15 of pregnancy, the multilayered subplacenta (SP), and the ini- tial sprouts that give origin to the placenta, expressed K1, MMP-2 and MMP-9 Figure 1
In subsequent sections of a uteroplacental unit obtained in day 15 of pregnancy, the multilayered subplacenta (SP), and the ini-
tial sprouts that give origin to the placenta, expressed K1, MMP-2 and MMP-9. Syncytiotrophoblasts composing the interlobium 
and the labyrinth expressed K1, MMP-2 and MMP-9 in sections obtained in days 20, 40 and 60 of pregnancy. Bar = 50 μm.
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Western blot analysis
Equal amounts of protein (100 μg/lane) were separated
using 10% SDS-PAGE under reducing conditions and
transferred to nitrocellulose membranes (Biorad, Her-
cules, CA), blocked with 5% nonfat dry milk in PBS-0.1%
Tween-20 buffer (PBS-T) and incubated overnight at 4°C
with the same primary antibodies used in immunohisto-
chemistry: anti-MMP-2 (1 μg/ml), anti-MMP-9 (1 μg/ml)
or anti-K1 (1:8000) diluted in blocking buffer.
Standards were purified human recombinant proMMP-2,
proMMP-9 (20 ng, Calbiochem, La Jolla, CA), and puri-
fied rat urinary kallikrein (5 ng) [27]. The membranes
were washed six times for five minutes in PBS-T buffer,
incubated with HRP-conjugated anti-mouse or anti-rabbit
secondary antibodies (both 1:3000, Biorad, Hercules, CA)
for one hour at room temperature and developed with
chemiluminescence reagent (NEL-103, Western Lighting,
Perkin-Elmer, MA) [30]. Membranes were exposed to CL-
xPosure film (Pierce, Rockford, IL). Equal protein loading
was confirmed with Ponceau-S red staining (Sigma, St.
Louis, MO). Images were scanned at 16-bit/600dpi reso-
lution with an Epson Perfection 3490 scanner (Epson
Corporation, CA), saved as tiff files and calibrated to an
optical density scale. The integrated optical density of
bands was quantitated using the ImageJ v.1.34 software
and expressed as fold- values of the average optical density
at day 20 ± SE for K1. For MMP-2 and MMP-9, the optical
Western blot analysis of guinea-pig placental homogenates for MMP-2 Figure 2
Western blot analysis of guinea-pig placental homogenates for MMP-2. A, Representative blot at days 20, 40 and 60 of preg-
nancy. Purified human proMMP-2 (hProMMP-2) yielded two bands with approximate molecular weights of 72 and 62 kDa. B, 
Mean ratio of active/total MMP-2 in three placental homogenates for each period showed no significant differences. DSCF post-
hoc comparisons after Kruskal-Wallis test.
ProMMP-2
MMP-2
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densities were expressed as the ratio of active/total
enzyme (total equals the sum of the optical densities of
the bands).
Gelatin zymography
Gelatinase activity was detected by zymography using
methods described previously with some modifications
[31]. Placental proteins (100 μg/lane) were resolved
under non reducing conditions in an 8% polyacrylamide
gel containing 0.5 mg/ml gelatin (porcine skin, 300-
bloom, Sigma, St. Louis, MO). After electrophoresis, the
gels were washed twice at room temperature for 30 min-
utes in 2.5% Triton X-100, subsequently washed in buffer
containing 50 mM Tris-HCl, 150 mM NaCl, 5 mM CaCl2,
1 μM ZnCl2, 0.05% Brij-35, 0.02% NaN3 at pH 7.5 and
incubated in this buffer at 37°C for 24 h. Thereafter, the
gels were stained with 0.2% (w/v) Coomassie brilliant
blue R-250 (Sigma, St. Louis, MO) for one hour, lightly
destained in methanol:acetic acid:water (3:1:6) and
finally stored in 5% acetic acid. Identification of each gela-
tinase band was done in accordance to their molecular
weight using purified human recombinant proenzymes
MMP-2 and MMP-9 as standards (0.25 ng). Gels were
scanned in transmissive mode at 16-bit color/600dpi
(Epson Perfection 3490, Epson, CA) and stored in tiff for-
mat. Images were processed extracting the blue channel
signal, converted to black and white and inverted for
quantitation of the integrated optical density of gelatino-
lytic activities using the ImageJ v.1.34 software. Data was
Western blot analysis of guinea-pig placental homogenates for MMP-9 Figure 3
Western blot analysis of guinea-pig placental homogenates for MMP-9. A, Representative blot at days 20, 40 and 60 of preg-
nancy. Purified human proMMP-9 (hProMMP-9) yielded two bands with approximate molecular weights of 92 and 68 kDa. B, 
Mean ratio of active/total MMP-9 in five placental homogenates for each period. **P < 0.01 for 20 vs. 40 days; ***P < 0.001 for 
40 vs. 60 days. DSCF posthoc comparisons after Kruskal-Wallis test.
ProMMP-9
MMP-9
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expressed as fold-values of the average optical density at
day 20.
Statistical analysis
Overall differences between the three studied periods of
pregnancy were assessed with the Kruskal-Wallis test with
posthoc  unpaired comparisons using the Dwass-Steel-
Chritchlow-Fligner (DSCF) test. All analyses were per-
formed with the StatsDirect v.2.6.1 software (StatsDirect
Ltd., Cheshire, UK). Statistical significance was set at P <
0.05. Results are expressed as means ± SE.
Results
Spatio-temporal expression of MMP-2, MMP-9 and K1 in
uteroplacental units
Subplacenta
The folded multilaminar layer of cytotrophoblasts that
constitutes the subplacenta appeared to be the main, if
not the exclusive, source of trophoblasts. Clusters of syn-
cytiotrophoblast, which constituted the earliest expres-
sion of the placenta, were observed at day 15 of gestation
towards the uterine lumen of the subplacenta. From its
Western blot analysis of guinea-pig placental homogenates for tissue kallikrein (K1) Figure 4
Western blot analysis of guinea-pig placental homogenates for tissue kallikrein (K1). A, Representative blot at days 20, 40 and 
60 of pregnancy. Purified rat K1 (rK1) was detected as a broad band with an approximate molecular weight of 31 kDa. B, Den-
sitometric analysis of K1 expression in five placental homogenates for each period. Data is expressed with respect to the aver-
age densitometry at day 20. *, P < 0.05 for 60 vs. 40 days; ***, P < 0.001 for 40 vs. 20 days. DSCF posthoc comparisons after 
Kruskal-Wallis test.
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Gelatin zymography of placental homogenates Figure 5
Gelatin zymography of placental homogenates. A, Representative zymogram at days 20, 40 and 60 of pregnancy. Purified 
human proMMP-2 (hproMMP-2) and proMMP-9 (hproMMP-9) were used as standards. B-C, Densitometric analysis of zymo-
grams from three placental homogenates at days 20, 40 and 60 for Pro/MMP-2 (B) and Pro/MMP-9 (C). Data is expressed with 
respect to the average densitometry at day 20. *, P < 0.05 for 40 vs. 20 and 60 days in (B); *, P < 0.05 for 40 and 60 vs. 20 days 
in (C). DSCF posthoc comparisons after Kruskal-Wallis test.
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base also rose syncytial sprouts, which penetrated the
endometrium. At this stage, the subplacental cytotro-
phoblasts expressed MMP-2, MMP-9 and K1 (Fig. 1). The
positive subplacental immunoreactivity was observed
throughout pregnancy. The groups of multinucleated
giant cells found in the junctional zone close to the
decidua also showed staining for these enzymes (not
shown).
Placenta
As early as day 15, trabeculae and syncytiotrophoblast
plates originated from the subplacenta, and expressed
immunoreactivity for MMP-2, MMP-9 and K1. This gran-
Trophoblasts characterized by cytokeratin (CK) in the subplacenta (SP) and in the decidual syncytial streamers (ST) expressed  MMP-2, MMP-9 and K1 in sequential sections of days 15, 20 and 40 of pregnancy Figure 6
Trophoblasts characterized by cytokeratin (CK) in the subplacenta (SP) and in the decidual syncytial streamers (ST) expressed 
MMP-2, MMP-9 and K1 in sequential sections of days 15, 20 and 40 of pregnancy. Bar = 50 μm
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ular staining persisted in the thick bands of syncytiotro-
phoblast of the interlobium and in the thin trabeculae
composed by syncytium and endothelial cells of the laby-
rinth, from their development to term (Fig. 1).
Western blot analysis of placental homogenates at days
20, 40 and 60 of pregnancy identified bands correspond-
ing to the molecular weights of MMP-2, MMP-9 and K1.
The bands corresponding to pro and active MMP-2 did
not show a significant change of expression as pregnancy
progressed (Fig. 2A); as expected, the ratio of active/total
MMP-2 remained constant along pregnancy (Fig. 2B).
ProMMP-9 expression decreased at day 40 (P  < 0.05)
while active MMP-9 attained its lowest expression at day
60 (P < 0.05; Fig. 3A). The ratio of active/total MMP-9
increased significantly at mid- pregnancy (P < 0.01; Fig.
3B), in parallel to the highest K1 expression level (P <
0.05; Fig. 4A,B).
Gelatinase activity was detected in homogenates of pla-
centae at 20, 40 and 60 days of pregnancy, with two bands
of 72 and 92 kDa, thus matching the predicted size of the
latent forms of MMP-2 and MMP-9. Another two bands
with weights ~10 kDa lower than the latent forms were
detected, probably corresponding to the active forms of
MMP-2 and MMP-9. ProMMP-2 and ProMMP-9 gelati-
nase activities did not show variations along pregnancy,
while active MMP-2 increased at 40 days (P < 0.05), and
active MMP-9 increased at 40 and 60 days (P < 0.05) com-
pared to day 20 of pregnancy (Fig. 5A,B,C).
Endometrium
As early as day 15 of gestation, cytokeratin positive cells
were observed in the capillary walls, and invasive tro-
phoblasts coalesced into syncytial streamers, or finger-like
columns migrating into the endometrium. From day 20
onwards, plugs were observed in some arterial lumina
(not shown).
MMP-2, MMP-9 and K1 immunoreactivity in streamers
showed a granular staining (Fig. 6). The area occupied by
streamers, quantified by digital analysis, was increased in
midpregnancy, as compared to the early and late stages
(1,163 ± 62 versus 944 ± 91 and 644 ± 39 μm2, P < 0.01).
In addition, the signal intensity increased in mid and late
pregnancy for MMP-2 (4.1 ± 0.2 and 4.0 ± 0.1 versus 3.1
Spiral arteries observed in sequential sections of myometrium obtained in days 40 and 60 of pregnancy, expressed MMP-2,  MMP-9 and K1 in trophoblasts surrounding the vessel, characterized by cytokeratin (CK), and in the swollen endothelial cells,  characterized by von Willebrand Factor (vWF) Figure 7
Spiral arteries observed in sequential sections of myometrium obtained in days 40 and 60 of pregnancy, expressed MMP-2, 
MMP-9 and K1 in trophoblasts surrounding the vessel, characterized by cytokeratin (CK), and in the swollen endothelial cells, 
characterized by von Willebrand Factor (vWF). The remaining vascular smooth muscle in day 40 was positive for muscle actin 
(MA), and has been replaced in day 60. Bar = 50 μm
40 Days
60 Days
MMP-2           MMP-9            K1                   CK                   MA        vWF
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± 0.2 dB/μm2 in early pregnancy, P < 0.05), decreased in
late pregnancy for MMP-9 (3.0 ± 0.1 versus 3.6 ± 0.2 and
3.8 ± 0.2 dB/μm2 in early and mid- pregnancy, P < 0.05),
and remained stable for K1 (pooled average 4.0 ± 0.1 dB/
μm2).
Spiral and mesometrial arteries
Spiral arteries in mid- pregnancy were surrounded by
cytotrophoblasts, which had partly disrupted the vascular
smooth muscle layer, and expressed MMP-2, MMP-9 and
K1. These enzymes were also observed in swollen
endothelial cells. In late pregnancy cytotrophoblasts
replaced the smooth muscle layer and attained the lumi-
nal border; these cells presented a diffuse staining for
MMP-2 and a granular staining for MMP-9 and K1.
Endothelial cells, identified by vWF were swollen, and
expressed the three enzymes (Fig. 7).
Mesometrial arteries in early and mid pregnancy had a
thick multilayer zone of smooth muscle cells and no tro-
phoblasts were observed in their periphery or within the
muscle layer. In late pregnancy trophoblasts replaced part
of the muscle layer, and presented a positive signal for
MMP-2, MMP-9 and K1. Endothelial cells, identified by
vWF, were swollen and expressed MMP-9 and K1 (Fig. 8).
Control sections incubated in absence of the first anti-
body yielded no staining in different structures and stages
of pregnancy (Fig. 9).
Discussion
The present study represents the first demonstration of the
expression of MMPs and K1, as well as their coincident
localization in different cell types of the feto-maternal
interface of the guinea-pig. The spatio-temporal localiza-
Mesometrial arteries obtained in day 40 of pregnancy showed in sequential sections an intact smooth muscle layer character- ized by muscle actin (MA), and no cytokeratin positive cells Figure 8
Mesometrial arteries obtained in day 40 of pregnancy showed in sequential sections an intact smooth muscle layer character-
ized by muscle actin (MA), and no cytokeratin positive cells. In day 60, intramural trophoblasts, characterized by cytokeratin 
(CK), expressed MMP-2, MMP-9 and K1, while endothelial cells, identified by von Willebrand Factor (vWF), were swollen, and 
expressed MMP-9 and K1. The remaining vascular smooth muscle, positive for muscle actin (MA), was disrupted. Bar = 50 μm
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tion of these enzymes in critical sites and periods of the
placentation process, as well as the modulation in the
activity of MMPs, suggest a functional role in relation to
trophoblast invasion and placental angiogenesis.
The immunohistochemical expression of MMP-2 and
MMP-9 in placental syncytiotrophoblasts, subplacenta
and invading trophoblasts in the guinea-pig is similar to
that reported in the human feto-maternal interface in the
syncytium, anchoring columns and invasive trophoblasts
respectively [11-15], cell types that perform similar func-
tions. This statement derives from the fact that the subpla-
cental trophoblasts contact the uterine wall and are the
main – if not exclusive – source of invading trophoblasts,
thus being comparable to the anchoring villi; the syncytial
streamers of the guinea-pig, though fused, represent the
invasive trophoblasts, and the peri and intraarterial tro-
phoblasts are shared by both species.
Since the antibodies used for immunohistochemistry in
the present study do not differentiate active from inactive
MMPs, the addition of Western Blot and zymography of
placental homogenates showed a modulation of the
enzymes. A more exact analysis of the variations of MMP
activity in the different structures of the utero-placental
unit needs to be pursued using in situ gelatin zymography.
In syncytial streamers, the immunoreactive expression of
MMPs, semiquantified by digital analysis, increased for
MMP-2 in mid- and late pregnancy, while for MMP-9
decreased in late pregnancy. The variations of the immu-
noreactivity in streamers, support a temporal regulation.
In humans, data derived from placental sections and from
trophoblasts in cultures [11,32] also show temporal vari-
ations of MMP-2 and MMP-9.
The immunoreactive expression of K1 in placenta, subpla-
centa, invasive and intraarterial cytotrophoblasts of the
guinea-pig is also similar to that found in equivalent cell
types and structures of the human utero-placental unit
[17]. In placenta, K1 was increased in mid- and late preg-
nancy. The intensity of the immunoreactive signal for K1
in syncytial streamers showed no variation along the dif-
ferent stages of pregnancy. It is important to relate the
expression of K1 to that of the B2R, the mediator of the
classical vasodilator effect of the tissue kallikrein-kinin
system. This receptor has been found by our group in
cytotrophoblasts of basal syncytial sprouts, in syncytial
streamers, in perivascular trophoblasts, and in placental
syncytium and endothelium [33]. The localization of the
enzyme and receptor of its main peptide support our
hypothesis that kinins favor angiogenesis and vasodila-
tion.
Several authors have found that K1 activates MMP-9 in
vitro  [19-21], therefore the coincident localization of
MMP-9 and K1, as well as the higher ratio of active/total
MMP-9 parallel to the highest expression of K1, favors a
Control sections at different days of pregnancy, incubated in absence of the first antibody for subplacenta (A), interlobium and  labyrinth (B-G), subplacenta and syncitial streamers (H), spiral arteries (I,J) and mesometrial artery (K) Figure 9
Control sections at different days of pregnancy, incubated in absence of the first antibody for subplacenta (A), interlobium and 
labyrinth (B-G), subplacenta and syncitial streamers (H), spiral arteries (I,J) and mesometrial artery (K). Bar = 50 μm
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functional association that could regulate MMP activation
in trophoblasts, and modify their invading capacity.
Trophoblast invasion shares many processes and mole-
cules with the proliferation and dispersion of cancer cells
[34]. MMPs have been extensively described in tumoral
cells, and are thought to be key facilitators of cell spread-
ing. K1 has also been recognized in several types of can-
cers, and has been related to the capability of kinins to
enhance mitosis, angiogenesis and vascular permeability
[16,35]. As stated above, and considering the increased K1
immunolabelling in extravillous trophoblast in placenta
accrete [17], we hypothesize that K1 may also contribute
to trophoblast invasion.
It is important to consider that MMPs are absolutely nec-
essary for vessel development. In tumors, MMP-2 and
MMP-9 play a critical role in the "angiogenic switch" [36].
The increased expression of the active form of MMP-9 in
day 40 of gestation, in a stage of rapid placental growth
[22], could be associated with enhanced vessel develop-
ment. As to the kallikrein-kinin system, angiogenic prop-
erties have been attributed to bradykinin [37,38].
Having analyzed a possible role for MMPs and K1 regard-
ing the invasion of the uterine stroma and placental ang-
iogenesis, the extensive penetration of trophoblasts
through the wall of spiral and mesometrial arteries
observed in the guinea-pig [39] deserves to be commented
in the same light. The increasing number of perivascular
and intramural cytotrophoblasts in mid and late preg-
nancy in spiral arteries, and the intramural trophoblasts in
late pregnancy in mesometrial arteries, expressed the triad
of MMP-2, MMP-9 and K1. As endovascular trophoblast
incorporation very likely depends on the same mecha-
nisms of interstitial stromal invasion, the activation of
MMP-9 by K1 may enhance the disruption of the suben-
dothelial basement membranes and other matrix compo-
nents of the vascular wall. We would like to emphasize
that in spite of occasional intravascular plugs, the main
route of vascular invasion in the guinea-pig is the intersti-
tium.
The interspecies conservation of MMPs and K1 immu-
nolocalization, the coincident localization of MMPs and
K1, and the modulation of these enzymes along preg-
nancy, supports a relevant and interrelated role of these
proteins in placental development. Though it is known
that inhibition of MMPs impairs trophoblast invasion in
vitro [40], there are no current studies of the effect of kal-
likrein and/or B2R inhibitors on trophoblast invasion. We
believe that the interrelated roles of MMPs and K1 sup-
ported by the present findings should motivate further
studies.
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